ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

ALT Altimmune Inc

6,50
-0,23 (-3,42%)
07 Jun 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Altimmune Inc ALT NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
-0,23 -3,42% 6,50 20:55:16
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
6,65 6,05 6,65 6,455 6,73
mais cotações »

Notícias Recentes

Data Hora Fonte Título
05/06/202408:00GLOBEAltimmune Presents Data at EASL International Liver..
05/06/202406:45PRNUSAltimmune, Inc. Sued for Securities Law Violations -..
29/05/202408:31GLOBEAltimmune to Participate at Two Upcoming Investor..
29/05/202408:30GLOBEAltimmune to Present Clinical Data from Pemvidutide at..
29/05/202406:45PRNUSThe Gross Law Firm Notifies Shareholders of Altimmune,..
21/05/202410:00PRNUSRoundhill Investments Launches GLP-1 & Weight Loss ETF..
21/05/202406:45PRNUSThe Gross Law Firm Notifies Altimmune, Inc. Investors of a..
14/05/202406:45PRNUSContact The Gross Law Firm by July 5, 2024 Deadline to Join..
10/05/202406:45PRNUSThe Gross Law Firm Announces the Filing of a Securities..
09/05/202418:51PRNUSINVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors..
09/05/202408:00GLOBEAltimmune Announces First Quarter 2024 Financial Results and..
07/05/202408:30GLOBEAltimmune to Participate at Two Upcoming Investor..
02/05/202408:30GLOBEAltimmune to Report First Quarter 2024 Financial Results and..
01/05/202408:30GLOBEAltimmune to Participate at Two Upcoming Conferences
25/04/202418:24GLOBEAltimmune Statement on the Passing of Dr. Stephen Harrison
27/03/202408:00GLOBEAltimmune Announces Positive Lean Mass Preservation Data for..
27/03/202407:57IHMARKETNEWSU.S. Stock Index Futures Point to a Rebound, Oil See..
20/03/202408:30GLOBEAltimmune to Report Fourth Quarter and Full Year 2023..
02/01/202409:30GLOBEAltimmune Announces Presentation of Pemvidutide Clinical..
08/12/202310:35GLOBEWater Tower Research US Climate Virtual Investor Conference:..
04/12/202310:35GLOBEWater Tower Research US Climate Investor Conference Agenda..
30/11/202318:24GLOBEAltimmune Announces Positive Topline Results from MOMENTUM..
07/11/202309:00GLOBEAltimmune Announces Third Quarter 2023 Financial Results and..
31/10/202308:30GLOBEAltimmune to Report Third Quarter 2023 Financial Results and..
26/10/202309:15DJNAltimmune Gets FDA Fast-Track Designation for Pemvidutide in..
26/10/202308:30GLOBEAltimmune Granted Fast Track Designation by FDA for..
25/10/202308:30GLOBEAltimmune to Present New Data on the Anti-Inflammatory and..
17/10/202308:30GLOBEAltimmune to Participate at Two Upcoming Investor..
26/09/202308:30GLOBEAltimmune Announces Oral Presentation of Pemvidutide..
12/09/202308:30GLOBEAltimmune Announces Completion of Dosing in the Phase 2..
30/08/202308:30GLOBEAltimmune to Participate at Two Upcoming Investor..
10/08/202308:00GLOBEAltimmune Announces Second Quarter 2023 Financial Results..
03/08/202308:30GLOBEAltimmune to Report Second Quarter 2023 Financial Results..
01/08/202308:30GLOBEAltimmune Announces Initiation of Phase 2b IMPACT Trial..
16/06/202308:30GLOBEAltimmune to Participate in the Healthcare Virtual..
15/06/202308:30GLOBEAltimmune Announces Oral Presentation of Pemvidutide..

Seu Histórico Recente

Delayed Upgrade Clock